Variants conferring risk of atrial fibrillation on chromosome 4q25
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in humans and is characterized by chaotic electrical activity of the atria. It affects one in ten individuals over the age of 80 years, causes significant morbidity and is an independent predictor of mortality. Recent studies have provided evidence of a genetic contribution to AF. Mutations in potassium-channel genes have been associated with familial AF but account for only a small fraction of all cases of AF. We have performed a genome-wide association scan, followed by replication studies in three populations of European descent and a Chinese population from Hong Kong and find a strong association between two sequence variants on chromosome 4q25 and AF. Here we show that about 35% of individuals of European descent have at least one of the variants and that the risk of AF increases by 1.72 and 1.39 per copy. The association with the stronger variant is replicated in the Chinese population, where it is carried by 75% of individuals and the risk of AF is increased by 1.42 per copy. A stronger association was observed in individuals with typical atrial flutter. Both variants are adjacent to PITX2, which is known to have a critical function in left-right asymmetry of the heart.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These biobank efforts, pioneered in studies such as the Framingham Cohort70 and the efforts of DeCODE in Iceland71,72, now encompass a growing inventory of national cohorts in North America, Europe, Asia and beyond73–76.”
From A brief history of human disease genetics (2020) · cites this paper as [71]
In the citing paper
“The most important variants are located close to the paired-like homeodomain transcription factor 2 gene on chromosome 4q25.63,64”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [63]
In the citing paper
“The AF-GRS comprised 12 SNPs that had been previously shown to be associated with AF at genome-wide significance.”
From Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke (2014) · cites this paper as [18]
In the citing paper
“These are all the SNPs that have been reported to be associated with AF at a genome-wide significance level (P<5×10−8), including 4 SNPs at PITX2 locus.18-23”
From Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke (2014) · cites this paper as [18]
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
A haplotype map of the human genome
The International HapMap Consortium (2005) · Nature · doi:10.1038/nature04226 · Cited by 5,858
Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Bailey, K. R., Abhayaratna, W. P., Seward, J. B., & Tsang, T. S. M. (2006) · Circulation · doi:10.1161/circulationaha.105.595140 · Cited by 2,564
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
Self-citationKCNQ1 Gain-of-Function Mutation in Familial Atrial Fibrillation
Chen, Y.-H., Xu, S.-J., Bendahhou, S., Wang, X.-L., Wang, Y., Xu, W.-Y., Jin, H.-W., Sun, H., Su, X.-Y., Zhuang, Q.-N., et al. (2003) · Science · doi:10.1126/science.1077771 · Cited by 1,000
FALK, C. T., & RUBINSTEIN, P. (1987) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1987.tb00875.x · Cited by 614
Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring
Fox, C. S. (2004) · JAMA · doi:10.1001/jama.291.23.2851 · Cited by 600
The gene encoding phosphodiesterase 4D confers risk of ischemic stroke
Gretarsdottir, S., Thorleifsson, G., Reynisdottir, S. T., Manolescu, A., Jonsdottir, S., Jonsdottir, T., Gudmundsdottir, T., Bjarnadottir, S. M., Einarsson, O. B., Gudjonsdottir, H. M., et al. (2003) · Nature Genetics · doi:10.1038/ng1245 · Cited by 564
Self-citationKv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation
Olson, T. M., Alekseev, A. E., Liu, X. K., Park, S., Zingman, L. V., Bienengraeber, M., Sattiraju, S., Ballew, J. D., Jahangir, A., & Terzic, A. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl143 · Cited by 491
Cited by
Items 901–949 of 949
Chia, R. N., Mehta, A. B., Huang, H. D., & Darbar, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.99761-8
Cardioprotective effects of coffee
Karaś, A., Kawałko, K., Pondel, K., & Bielewicz, K. (2022) · Journal of Education Health and Sport · doi:10.12775/jehs.2022.12.10.004
“Risk factors for atrial fibrillation can be divided into non-modifiable, such as genetic factors [13,14] or age [15,16], and modifiable.”
BackgroundLiew, R. (2012) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2011.11.018
Examining The Correlation between Patients with Atrial Fibrillation and eNOS G894 T PolymorphismPreprint
Kargün, K. (2022) · Research Square · doi:10.21203/rs.3.rs-2150670/v1
Ponomartseva, D. A., Hushkina, A. Y., Kostareva, A. A., & Babenko, A. Y. (2022) · Translational Medicine · doi:10.18705/2311-4495-2022-9-4-62-73
Khidirova, L. D., & Osmieva, Z. M. (2023) · Medical alphabet · doi:10.33667/2078-5631-2022-30-12-18
Deciphering the Intricate Molecular Bases of Atrial Fibrillation
Franco, D. (2023) · Hearts · doi:10.3390/hearts4040010
“Pioneering work by Gudbjartsson et al. [10] identified risk variants on the 4q25 locus that are significantly associated with lone AF.”
BackgroundGenetic basis of cardiovascular diseases
Roselli, C. (2023) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.827914096
Kardiogenetik in Deutschland – ein (Rück‑)Blick
Schulze‐Bahr, E. (2024) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-024-01008-y
Genetics of Small Vessel Disease
Marini, S., Parodi, L., Malik, R., & Anderson, C. D. (2024) · Springer eBooks · doi:10.1007/978-3-031-41777-1_13
Association between genotypes of ABCB1, ABCG2 and CYP3A5 and the risk of atrial fibrillationPreprint
Pan, T.-Y., Lin, T.-Y., Tsai, W., & Wu, M. (2024) · medRxiv · doi:10.1101/2024.07.09.24310172
Pharmacogenomics of Antiarrhythmic Drug Therapy for Atrial Fibrillation
Barney, M., & Darbar, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00018-2
Owais, A., & Darbar, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00010-8
Association between Genotypes of Abcb1, Abcg2 and Cyp3a5 and the Risk of Atrial FibrillationPreprint
Pan, T.-Y., Lin, T.-Y., Tsai, W., & Wu, M. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.5031338
Role of SNP markers on chromosome 10 in the pathogenesis of atrial fibrillation
Рифгатовна, С. А., Ryazanova, D. A., Yusupova, R., Makarov, M. A., Gataoullin, R. V., & Mardanova, N. F. (2025) · The Bulletin of Contemporary Clinical Medicine · doi:10.20969/vskm.2025.18(2).122-129
Zhuo, J., Wang, P., & Xu, C. (2025) · LabMed · doi:10.3390/labmed2040018
“Common genomic variants that contribute to the susceptibility of AF were also reported in several cohorts [7–10].”
Levicki, R., Trkulja, V., Pašara, V., Prepolec, I., Matovinović, M., Ganoci, L., Šegulja, D., Benčić, M. L., & Božina, T. (2025) · Diagnostics · doi:10.3390/diagnostics15222870
“In line with expectations [5–7, 28 , 29 ],”
Zigová, M., Petrejčíková, E., Blaščáková, M. M., Bernasovská, J., Boroňová, I., Kmec, M., & Kmec, J. (2025) · Journal of the Practice of Cardiovascular Sciences · doi:10.4103/jpcs.jpcs_46_25
Precision Medicine for Atrial Fibrillation Recurrence in East Asia
Aiba, T. (2026) · JACC Asia · doi:10.1016/j.jacasi.2025.11.012
Atrial fibrillation: genetic architecture and polygenic risk prediction
Yuan, S., Levin, M. G., & Larsson, S. C. (2026) · Heart · doi:10.1136/heartjnl-2025-326870 · Cited by 1
“11 These discoveries set the stage for progressively larger meta-analyses and biobank-scale studies that expanded the catalogue of common variant associations.”
Atrial fibrillation as a modern polygenic disease: a literature review
Дмитриевна, С. Е., Artyukhina, Е. А., & Revishvili, A. S. (2026) · Russian Journal of Cardiology · doi:10.15829/15604071-2025-6652
Ziyadeh-Isleem, A. (2014) · theses.fr (ABES) · doi:10.70675/ead6cb80z8324z43f0z8281zac5495e5661a
Omic approach to atrial fibrillation
Puertas, R. D. (2017) · theses.fr (ABES) · doi:10.70675/dd1855ebz1421z42e4zb00czd5476f4de207
Couturier, N. (2020) · theses.fr (ABES) · doi:10.70675/b29c05b3z1174z4c42z85fez962e19093010
Zhang, Z., Vlcek, J., Heger, C., Pauly, V., Hesse, N., Schüttler, D., Merkus, D., Wolf, E., Medugorac, I., Kääb, S., et al. (2026) · Basic Research in Cardiology · doi:10.1007/s00395-026-01176-7
“…4q25 by Gudbjartsson et al. increased AF risk by up to 1.72-fold per allele, affecting 35% of a European cohort and 75% of a Chinese cohort [21], potentially through alterations in action potential dynamics [52], more than 350 risk loci associated with AF susceptibility have been reported…”
InfluentialShiomi, M., Nagata, Y., Sudo, T., Takahashi, K., Higuchi, C., Ihara, K., Asada, K., Tanaka, Y., Yamauchi, Y., Sasaki, T., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0344360
“Among these, the 4q25 locus near PITX2 is one of the most consistently replicated genetic signals for AF susceptibility [8–11].”
Uncovering Novel Atrial Fibrillation Genetics Through Pleiotropic Overlap with Life’s Essential 8
Wu, J., Qin, X. Y., Shuting, X., Zheng, L. G., Yu, H., Wang, H., Chen, Y., Li, T., Wu, T., Chen, D., et al. (2026) · Biomedicines · doi:10.3390/biomedicines14061179
“Early genetic studies, including linkage studies [8,9], candidate-gene approaches [10], and subsequent genome-wide association studies (GWASs) [11–23], have identified numerous risk loci, implicating ion channel dysfunction, developmental programs and structural remodeling, and cytoskeletal…”
The Genetics of Atrial Fibrillation: From Molecular Mechanisms to Precision Medicine
Hinge, D. D., Shelke, A. B., Kawade, R., & Patil, S. (2026) · Cureus · doi:10.7759/cureus.109864 · Cited by 2
Atrial Fibrillation: Clinical Update and Review, Paradigm Shift of Rhythm Control
Nguyen, N. G. U. Y. E. N., Ha, T. T. P., Ahmad, S., Chu, T. A. T., & Nguyen, T. N. (2026) · TTU Journal of Science · doi:10.53901/tjs.2026.v01.issue02.art03
Bommineni, V. M., Morales, U. G., Yang, Z., Lerch, Z., Felix, M., & Ali, R. K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.11.731776
ГЕНЕТИЧНІ ПРЕДИКТОРИ ТА БІОМАРКЕРИ РИЗИКУ РОЗВИТКУ ФІБРИЛЯЦІЇ ПЕРЕДСЕРДЬ
Біла, Н., Володимирівна, Ш. І., Титаренко, Н., Слободянюк, І., & Павлюк, К. (2026) · Перспективи та інновації науки · doi:10.52058/2786-4952-2026-5(63)-2356-2374
Yan, Z., Pu, X., Cai, Y., Wu, Q., Zhang, X., Chang, X., Liu, J., Wang, Y., Liu, Z., & Liu, R. (2026) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-026-07902-6
Genetic Aspects of Atrial Fibrillation
Дмитриевна, С. Е., & Revishvili, A. S. (2026) · Cardiology and cardiovascular medicine. · doi:10.5772/intechopen.1014525
Lin, C., Wang, M., Tang, Y., & He, R. (2026) · Lecture notes in computer science · doi:10.1007/978-981-92-3716-6_19
Fields, A., Vo, J., Elsherbini, A., Hasheminia, A., Barzegar, N. S., Rodriguez, M., Abu‐Omar, Y., & El-Diasty, M. M. (2026) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2026.07.053
Genetic Determinants of Inherited Cardiac Arrhythmias
Brugada, R. (2026) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.1827
Szofer-Sendrowska, A., Sendrowska, M. K., Sendrowski, D., Słomiński, B., Lewandowski, K. K., Brzeziński, M., Lango, R., & Kowalik, M. M. (2026) · Research Square · doi:10.21203/rs.3.rs-10972015/v1
Multimodal deep learning enhances genomic risk prediction for cardiometabolic diseases
Zhu, T., Ghose, U., Climente-González, H., Howson, J. M. M., Hu, S., & Nevado‐Holgado, A. J. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbag550
“In atrial fibrillation and type 2 diabetes, the top GWAS loci, PITX2 and TCF7L2 , respectively, also received high DeepLIFT attributions [ 40, 41], both extensively validated across diverse populations.”
Mashkurova, Z., Zakirova, D., Abdullaeva, G., Radjabova, G., Yusupova, K., Pulatova, M., Shukurova, D., Ibrokhimov, N., Doniyorov, S., Sakhulova, N., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-11205616/v1
Advances in Genetic Susceptibility Genes and Molecular Pathogenesis of Atrial Fibrillation
张, 松. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.16103522
From 3D to 4D: spatiotemporal genome architecture and functional genomics in cardiovascular disease
Zhou, R., Yang, Y., Qiao, J., Yang, Y., Guzik, T. J., & Feng, Y. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag239
Gene Polymorphisms and Signaling Defects
Mannhalter, C., Poteser, M., & Groschner, K. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1334-9_4 · Cited by 1
Hamid, A. (2013) · Otago University Research Archive (University of Otago)
Studies of the genetic epidemiology of cardiovascular disease: focus on inflammatory candidate genes
Alanne, M. (2008) · Työväentutkimus Vuosikirja · Cited by 1
London, B. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.12.011
Polygenic Studies in the Risk of Arrhythmias
Sinner, M. F., & Kääb, S. (2009) · Springer eBooks · doi:10.1007/978-1-84882-927-5_22
Metadata
- Authors
- Gudbjartsson, D. F., Arnar, D. O., Helgadottir, A., Gretarsdottir, S., Holm, H., Sigurdsson, A., Jonasdottir, A., Baker, A., Thorleifsson, G., Kristjansson, K., Palsson, A., Blondal, T., Sulem, P., Backman, V. M., Hardarson, G. A., Palsdottir, E., Helgason, A., Sigurjonsdottir, R., Sverrisson, J. T., Kostulas, K., Ng, M. C. Y., Baum, L., So, W. Y., Wong, K. S., Chan, J. C. N., Furie, K. L., Greenberg, S. M., Sale, M., Kelly, P., MacRae, C. A., Smith, E. E., Rosand, J., Hillert, J., Ma, R. C. W., Ellinor, P. T., Thorgeirsson, G., Gulcher, J. R., Kong, A., Thorsteinsdottir, U., & Stefansson, K.
- Affiliations
- deCODE Genetics (Iceland) (IS)
- Karolinska University Hospital (SE)
- Chinese University of Hong Kong (HK)
- Harvard University (US)
- Corresponding author
- Gudbjartsson, Daniel F.
- ORCID
- Venue
- Nature
- Published
- 2007-07
- Volume
- 448
- Issue
- 7151
- Pages
- 353-357
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2037988353
- Cited by
- 955
- References
- 24
- Citations by year
- 2026: 23 · 2025: 23 · 2024: 36 · 2023: 38 · 2022: 32 · 2021: 32 · 2020: 48 · 2019: 39 · 2018: 53 · 2017: 68 · 2016: 63 · 2015: 48 · 2014: 59 · 2013: 68 · 2012: 67
- FWCI
- 43.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- Massachusetts General Hospital
- Landspítali Háskólasjúkrahús
- National Heart, Lung, and Blood Institute (R01HL075431)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- atrial fibrillation, chromosome 4q25, PITX2, genetic risk factors, cardiac arrhythmias, atrial flutter, heart development, genetic association, Chinese population, European populations
- MeSH terms
- Aged, Aged, 80 and over, Atrial Fibrillation, Chromosomes, Human, Pair 4, Female, Gene Frequency, Haplotypes, Hong Kong, Humans, Iceland, Male, Middle Aged, Sweden, United States, Genetic Variation, Genome, Human, Age Distribution, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, White People, Asian People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.